Výsledky vyhledávání

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Elicitation of mutual understanding and achievement of coherence

Autor: Lala U. Takeda

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ef8b2ae472d131b259daefe439210af
https://doi.org/10.4324/9781003008903-3

Zobrazit plný text záznamu

[Roles and problems of nurses taking care of terminally-ill patients at home]

Autor: U, Takeda

Publikováno v: Gan to kagaku ryoho. Cancerchemotherapy. 25

Since May in 1994, we have started to take care of terminally-ill patients at home to support patients who want to die at home and their family. Many patients in the terminal stage become stable temporarily from being back home, and their family are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6659f2ea9ec64828f79a840bb4096cae
https://pubmed.ncbi.nlm.nih.gov/9884639

Zobrazit plný text záznamu

[A consideration in regard to 16 patients died at home]

Autor: Y, Hashimoto, H, Tanizawa, Y, Ushitani, T, Shinoda, N, Yaeo, U, Takeda, Y, Tsukada

Publikováno v: Gan to kagaku ryoho. Cancerchemotherapy. 22

We had given the service to the patients who desired home care. And now we made inquiries about 16 cases died at home. They were satisfied with our service and death at home. But in regard to the question "If you die at home, Are you satisfied?¿, ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a65838e4d76698ad5dd3fa73238ba242
https://pubmed.ncbi.nlm.nih.gov/8849273

Zobrazit plný text záznamu

Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-9. Toxicity of metabolites of miocamycin: subacute toxicity of Mb6 in rats

Autor: M, Yokota, U, Takeda, M, Odaki, H, Sasaki, T, Niizato, H, Kawaoto, H, Watanabe, N, Ishiwatari, H, Hayasaka, T, Koeda

Publikováno v: The Japanese journal of antibiotics. 37(8)

Miocamycin (MOM) is a derivative of midecamycin and is metabolized into 4 main metabolites of Mb1, Mb2, Mb6 and Mb12. It is also known that LD50 values of Mb6 were 4,150 mg/kg in male mice and 4,000 mg/kg in female mice but LD0 values in male and fem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b84eb436912a50232a210fb08820d2ef
https://pubmed.ncbi.nlm.nih.gov/6334179

Zobrazit plný text záznamu

Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-6. Toxicity of metabolites of miocamycin: subacute toxicity of Mb2 in rats

Autor: M, Yokota, U, Takeda, M, Odaki, H, Sasaki, T, Niizato, H, Kawaoto, H, Watanabe, N, Ishiwatari, H, Hayasaka, T, Koeda

Publikováno v: The Japanese journal of antibiotics. 37(8)

Miocamycin (MOM) is a derivative of midecamycin, a macrolide antibiotic and is metabolized into 4 main metabolites of Mb1, Mb2, Mb6 and Mb12. At previous study, the acute and subacute toxicity of Mb1 and acute toxicity of Mb2 were performed that thos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b4755844ab3065e4ab186600ff8ecc20
https://pubmed.ncbi.nlm.nih.gov/6334176

Zobrazit plný text záznamu

Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miokamycin). Part III-1. Chronic toxicity in rats

Autor: M, Yokota, U, Takeda, M, Odaki, H, Sasaki, T, Niizato, H, Kawaoto, H, Watanabe, T, Itoh, N, Ishiwatari, T, Koeda

Publikováno v: The Japanese journal of antibiotics. 37(7)

Miokamycin (MOM) is a derivative of midecamycin, a macrolide antibiotic isolated from a culture broth of Streptomyces mycarofaciens. The objective of this study was to determine the chronic toxicity of MOM in male and female rats (Wistar, SPF, 5-week

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f003f7f1884525bd36b7d39d20102d03
https://pubmed.ncbi.nlm.nih.gov/6333530

Zobrazit plný text záznamu

Toxicological studies on a new macrolide antibiotic, midecamycin acetate (miocamycin). Part IV-12. Toxicity of metabolites of miocamycin: subacute toxicity of Mb12 in rats

Autor: M, Yokota, U, Takeda, M, Odaki, H, Sasaki, T, Niizato, H, Kawaoto, H, Watanabe, N, Ishiwatari, H, Hayasaka, T, Koeda

Publikováno v: The Japanese journal of antibiotics. 37(8)

Miocamycin (MOM) is a derivative of midecamycin and is metabolized into 4 main metabolites of Mb1, Mb2, Mb6 and Mb12. In the previous study, LD0 values of Mb12 in male and female rats were estimated more than 5,000 mg/kg. The object of this study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::630e115fd154b8d09e3dce35286b49d8
https://pubmed.ncbi.nlm.nih.gov/6334182

Zobrazit plný text záznamu

The intravenous toxicity of dibekacin sulphate (DKB) to female beagle dogs

Autor: R W, James, P F, Wadsworth, H, Chesterman, S A, Ball, S K, Majeed, R, Heywood, A E, Street, T, Koeda, U, Takeda, H, Sasaki

Publikováno v: The Japanese journal of antibiotics. 33(8)

Dibekacin sulphate (DKB), a new aminoglycoside antibiotic developed on the theory of bacterial resistance, was given by intravenous injection to groups of female Beagle dogs at dosages of 2.5, 5.0, 10.0 or 25.0 mg/kg/day for 13 weeks. Physiological s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cbd8e53f477de01f7cc735c9593c497b
https://pubmed.ncbi.nlm.nih.gov/7206221

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání